XML 46 R29.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 9 - Financial Instruments With Off-balance-sheet Risk (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Notes Tables |
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block] |
|  | December 31, 2023 |  |  | December 31, 2022 |
|  |  |  |  |  | Fair Value of |  |  |  |  |  |  | Fair Value of |
|  |  |  |  |  | Unfunded |  |  |  |  |  |  | Unfunded |
|  | Principal |  |  | Commitment |  |  | Principal |  |  | Commitment |
|  | Balance |  |  | Liability |  |  | Balance |  |  | Liability |
|  | (In thousands) |  |  | (In thousands) |
BrightInsight, Inc. |  | $ | 15,500 |  |  | $ | 241 |  |  | $ | 21,000 |  |  | $ | 278 |
Britecore Holdings, Inc. |  |  | 5,000 |  |  |  | 72 |  |  |  | 5,000 |  |  |  | 66 |
Candesant Biomedical Corporation |  |  | 10,000 |  |  |  | 151 |  |  |  | — |  |  |  | — |
Castle Creek Biosciences |  |  | — |  |  |  | — |  |  |  | 4,000 |  |  |  | 72 |
Divergent Technologies, Inc. |  |  | 11,250 |  |  |  | 118 |  |  |  | 22,500 |  |  |  | 236 |
Elligo Healthcare Research, Inc. |  |  | 15,000 |  |  |  | 194 |  |  |  | — |  |  |  | — |
Engage3, LLC |  |  | — |  |  |  | — |  |  |  | 8,000 |  |  |  | 40 |
Groundspeed Analytics, Inc. |  |  | — |  |  |  | — |  |  |  | 15,000 |  |  |  | 150 |
Hound Labs, Inc. |  |  | — |  |  |  | — |  |  |  | 7,500 |  |  |  | 88 |
KSQ Therapeutics, Inc. |  |  | — |  |  |  | — |  |  |  | 10,000 |  |  |  | 100 |
Lytics, Inc. |  |  | — |  |  |  | — |  |  |  | 5,000 |  |  |  | 65 |
MicroTransponder, Inc. |  |  | 22,500 |  |  |  | — |  |  |  | — |  |  |  | — |
Mirantis, Inc. |  |  | 15,000 |  |  |  | 136 |  |  |  | — |  |  |  | — |
Native Microbials, Inc. |  |  | — |  |  |  | — |  |  |  | 7,500 |  |  |  | 72 |
Optoro, Inc. |  |  | 6,250 |  |  |  | — |  |  |  | 15,000 |  |  |  | 38 |
Parse Biosciences, Inc. |  |  | 15,000 |  |  |  | 251 |  |  |  | — |  |  |  | — |
PDS Biotechnology Corporation |  |  | — |  |  |  | — |  |  |  | 10,000 |  |  |  | 158 |
Robin Healthcare, Inc. |  |  | — |  |  |  | — |  |  |  | 10,000 |  |  |  | 100 |
SafelyYou, Inc. |  |  | 20,000 |  |  |  | 270 |  |  |  | — |  |  |  | — |
Scientia Vascular, Inc. |  |  | — |  |  |  | — |  |  |  | 10,000 |  |  |  | 110 |
Slingshot Aerospace, Inc. |  |  | — |  |  |  | — |  |  |  | 5,000 |  |  |  | 64 |
Sonex Health, Inc. |  |  | 15,000 |  |  |  | 176 |  |  |  | — |  |  |  | — |
Supply Network Visibility Holdings, LLC |  |  | 10,000 |  |  |  | 35 |  |  |  | — |  |  |  | — |
Swift Health Systems Inc. |  |  | — |  |  |  | — |  |  |  | 25,500 |  |  |  | 105 |
Tallac Therapeutics, Inc. |  |  | 10,000 |  |  |  | 229 |  |  |  | — |  |  |  | — |
Temperpack Technologies, Inc. |  |  | — |  |  |  | — |  |  |  | 9,000 |  |  |  | 19 |
Viken Detection Corporation |  |  | 10,000 |  |  |  | 160 |  |  |  | — |  |  |  | — |
Total |  | $ | 180,500 |  |  | $ | 2,033 |  |  | $ | 190,000 |  |  | $ | 1,761 |

X
- Definition Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined) which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration